Page 517 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition
P. 517

CHAPTER 24  Tumors of the Respiratory System  495


           Pathology and Natural Behavior                        History and Clinical Signs

           Carcinomas, including adenocarcinoma, SCC, and undifferenti-  Although many intranasal diseases will have overlapping clinical
  VetBooks.ir  ated carcinoma represent nearly two-thirds of canine intranasal   signs, a strong suspicion of cancer is appropriate for older animals
                 34
                                                                 with an intermittent and progressive history of unilateral (initially)
           tumors.  Sarcomas (usually fibrosarcoma, chondrosarcoma,
           osteosarcoma, and undifferentiated sarcoma) comprise the bulk of
                                                                                                                these
                                                                                                           25,74
           the remaining cancers.  Both carcinomas and sarcomas are char-  epistaxis or mucopurulent discharge (or both). The average dura-
                                                                 tion of clinical signs before diagnosis is 2 to 3 months;
                            35
           acterized by progressive local invasion. The metastatic rate is gen-  most commonly include epistaxis, bloody or mucopurulent nasal
           erally considered low at the time of diagnosis but may be as high   discharge, facial deformity due to bone erosion and subcutaneous
           as 40% to 50% at the time of death, which is usually attributable   extension of tumor, unwillingness to open the mouth, sneezing,
                                                    26
           to the primary disease rather than metastatic lesions.  The most   dyspnea or stertorous breathing, exophthalmos, and ocular dis-
           common sites of metastasis are the regional lymph nodes (LNs)   charge as a result of mechanical obstruction of the nasolacrimal
           and the lungs. 26,35,36  Less common sites include bones, kidneys,   duct. 25,34,74  Differential diagnoses for animals with these clinical
           liver, skin, and brain. 37–40                         signs include fungal (Aspergillus sp.) or bacterial rhinitis, idio-
             Rare tumors of the sinonasal region in dogs include round   pathic nonspecific rhinitis (usually lymphoplasmacytic), rare nasal
           cell tumors (such as lymphoma), mast cell tumor (MCT), and   parasites, bleeding disorders, hypertension, foreign body, trauma,
           transmissible venereal  tumor. Other  malignancies  include  hem-  and developmental anomalies (e.g., cystic Rathke’s clefts). 75–77
           angiosarcoma, melanoma, neuroendocrine carcinoma, nerve   If facial deformity is present, the diagnosis is almost always can-
           sheath tumor, neuroblastoma, fibrous histiocytoma, multilobular   cer; 78–79  however, aspergillosis, sporotrichosis, and a rare, benign
           osteochondrosarcoma, hamartoma, rhabdomyosarcoma, and leio-  condition, angiomatous proliferation of the nasal cavity or angio-
           myosarcoma. 26,41–58  The biologic behavior of these less common   fibroma, also can cause facial deformity. In a retrospective study of
           malignancies is not well defined, although small retrospective case   105 cases of dogs with intranasal disease, the characteristics of the
           series have been reported for lymphoma, intranasal MCT, and mel-  nasal discharge were evaluated to determine whether they corre-
           anoma. 59–62  Benign, yet often locally invasive lesions such as polyps,   lated with diagnosis.  In dogs with confirmed neoplasia (n = 23),
                                                                                80
           fibromas, dermoid cysts, and angiofibroma can also be seen. 63,64  the median duration of discharge was 60 days. Mucoid discharge
             A number of studies have attempted to elucidate possible   in pure or mixed form was seen more frequently in neoplasia com-
           molecular mechanisms associated with canine sinonasal tumori-  pared with fungal, nonspecific rhinitis and foreign body cases.
           genesis. In one study using a single polyclonal antihuman anti-  When signs lasted more than 14 days, hemorrhagic discharge was
           body, nuclear p53 accumulation was detected in nearly 60% of   seen more commonly in dogs with neoplasia compared with those
           nasal adenocarcinomas (11 of 19), which suggests that overexpres-  with rhinitis or other causes. Nasal stridor was also noted more
                                                            65
           sion of a mutated p53 tumor suppressor protein may play a role.    often in dogs with neoplasia.
           Cyclooxygenase-2 (COX-2) expression has been detected to vary-  Clinical signs can be temporarily alleviated by a variety of
           ing degrees in most sinonasal epithelial tumors sampled 66–69  and   symptomatic treatments, including antibiotics, steroids, and non-
                                                            69
           in normal paratumoral respiratory epithelium and stromal tissue.    steroidal antiinflammatory drugs (NSAIDs).  An initial response
                                                                                                   74
           In one study, epidermal growth factor receptor (EGFR) expression   to these treatments should not diminish the index of suspicion for
           and vascular endothelial growth factor (VEGF) expression were   neoplasia in older dogs with clinical signs consistent with cancer. 74
           detected in over 50% and 90% of the 24 nasal carcinomas evalu-  On rare occasions, animals with tumors involving the caudal
                        70
           ated, respectively.  All tumors expressed either EGFR or VEGF,   region of the nasal cavity may have only neurologic signs (e.g.,
           but there was no association between the immunoreactivity for   seizures, acute blindness, behavior change, paresis, circling, and
                     70
           each protein.  To evaluate expression of receptor tyrosine kinases   obtundation) caused by direct invasion of the cranial vault. 55,56,81
           (RTKs) with the intent to establish a rationale for use of TK inhib-  However, absence of neurologic signs does not rule out tumor exten-
           itors (TKIs), VEGFR2 and platelet derived growth factor receptor   sion into the cranial vault because most dogs with nasal tumors that
           (PDGFR) α and β have been evaluated in 187 nasal carcinoma   extend beyond the cribriform plate do not exhibit neurologic signs. 
                 71
           samples.  VEGFR was expressed in 84% of the samples and was
           predominantly cytoplasmic-membranous, similar to what is seen   Diagnosis and Staging
           in high grade MCTs. PDGFRα was noted in 71% of cases and
           PDGFRβ in 40%, both with weak to moderate intensity. Coex-  A definitive diagnosis of sinonasal cancer requires a tissue biopsy,
           pression of RTKs was common. The authors concluded that stud-  even though diagnostic imaging and historic information can be
                                                 71
           ies evaluating clinical utility of TKIs are warranted.  Expression of   highly suggestive. Coagulation disorders must be ruled out before
           peroxisome proliferator-activated receptor γ (PPAR-γ), a nuclear   biopsy because bleeding during the procedure is to be expected.
           receptor involved in glucose metabolism and fatty acid storage,   The superior imaging value of CT and MRI over conven-
           has also been shown in canine nasal carcinomas.  The authors of   tional radiographs for canine nasal disease, including neoplasia,
                                                72
           that study suggested that expression patterns may differ in tumor   is well documented. 27,49,75,82–88  Cross-sectional imaging provides
           tissue compared with normal nasal epithelium.  The role of these   improved anatomic detail, which allows accurate determination
                                              72
           proteins in carcinogenesis is not clear, and further investigation is   of the extent of tumor (staging) and localization of nasal cavity
           needed before clinical relevance can be determined. Evaluation of   abnormalities (Fig. 24.4). 27,49,75,82–88  It also facilitates evaluation
           the inflammatory infiltrate in 31 canine nasal carcinomas revealed   of the integrity of the cribriform plate and identification of poten-
           an abundance of neutrophils and macrophages, which were pres-  tial tumor extension into the cranial vault. Although, in general,
           ent in greater numbers than in normal canine mucosa.  Plasma   MRI allows for better resolution of soft tissue structures, one
                                                      73
           cells and T lymphocytes were also detected; however, levels did   report showed no clinically relevant benefit to using MRI over
           not correlate with particular tumor subtype.          CT to evaluate nasal tumors that do not extend into the cranial
   512   513   514   515   516   517   518   519   520   521   522